Even 31% ABOVE ALL SOC DRUGS as a mortality benefit are an excellent results for those whose life leronlimab saved.. We can only imagine the results if study will not be sabotaged , and patients could have 4 doses ...
And all this without one serious side effect.
Not only that , but leronlimab plus SOC had less side effects then SOC only .. This telling me that leronlimab corrected some side effects from SOC drugs..
Unfortunately study sabotage is to blame, not our extraordinary LERONLIMAB that all seem to want, especially that 13d group of thieves... there are fools within the FDA who are bought and sold daily... it's an undeniable racket out there at the expense of many a life. FACTS!
News 
Market Data 
Discover 
